In Alzheimer’s disease, Aβ-induced oxidative stress and microglial activation have both proven to be mediators of MAPK p38 signalling [166,167,168], which promotes apoptosis but also acts as a kinase of tau protein [169], further contributing to Alzheimer’s disease (Figure 6 (9,10)). This evidence concerns the gene MAPK1 and Alzheimer disease.